Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis

Intensive Care Medicine Experimental

Volumn 3, Issue 1, 2015, Pages

  Martin Loeches, Ignacio ^a,b   Bos, Lieuwe D ^c   Povoa, Pedro ^d,e   Ramirez, Paula ^f   Schultz, Marcus J ^c   Torres, Antoni ^g   Artigas, Antonio ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

^e NOVA MEDICAL SCHOOL   (Portugal)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MALE; MICROBIAL IDENTIFICATION; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 85008158046     PISSN: None     EISSN: 2197425X     Source Type: Journal    
DOI: 10.1186/s40635-015-0062-1     Document Type: Article

References (29)

1. Torres A, Ewig S, Lode H, Carlet J (2009) Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 35:9–29
2. Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, DeWaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J (2009) Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 37:2360–8
3. Bassetti M, Taramasso L, Giacobbe DR, Pelosi P (2012) Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy. Expert Rev Anti Infect Ther 10:585–96
4. Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Marsh B, Torres A, Niederman MS, Rello J (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681
5. Ioanas M, Ferrer M, Cavalcanti M, Ferrer R, Ewig S, Filella X, de la Bellacasa JP, Torres A (2004) Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia. Crit Care Med 32:938–45
6. Póvoa P, Salluh JIF (2012) Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review. Ann Intensive Care 2:32
7. Bloos F, Marshall JC, Dellinger RP, Vincent J-L, Gutierrez G, Rivers E, Balk RA, Laterre P-F, Angus DC, Reinhart K, Brunkhorst FM (2011) Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care 15:R88
8. Moreno MS, Nietmann H, Matias CM, Lobo SM (2010) C-reactive protein: a tool in the follow-up of nosocomial pneumonia. J Infect 61:205–11
9. Luyt C-E, Combes A, Trouillet J-L, Chastre J (2011) Biomarkers to optimize antibiotic therapy for pneumonia due to multidrug-resistant pathogens. Clin Chest Med 32:431–8
10. Pencina MJ, D’Agostino RB, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–72, discussion 207–12
11. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM (1991) Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 143(5 Pt 1):1121–9
12. Ferrer M, Liapikou A, Valencia M, Esperatti M, Theessen A, Antonio Martinez J, Mensa J, Torres A (2010) Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. Clin Infect Dis 50:945–52
13. Vignali DA (2000) Multiplexed particle-based flow cytometric assays. J Immunol Methods 243:243–55
14. De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10:133–9
15. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP (2004) Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 61:35–9
16. Flahault A, Cadilhac M, Thomas G (2005) Sample size calculation should be performed for design accuracy in diagnostic test studies. J Clin Epidemiol 58:859–862
17. R Development Core Team (2010) Book R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
18. Harrell E Jr (2014) rms Regres Model Strateg R Packag version 41-3 http://CRANR-project.org/package=rms. Accesed 7th July 2015
19. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, Müller M (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77
20. Wickham H (2009) ggplot2: elegant graphics for data analysis. Springer, New York
21. Evangelidou M, Tseveleki V, Vamvakas S-S, Probert L (2010) TNFRI is a positive T-cell costimulatory molecule important for the timing of cytokine responses. Immunol Cell Biol 88:586–95
22. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306:2594–605
23. Kontermann RE, Münkel S, Neumeyer J, Müller D, Branschädel M, Scheurich P, Pfizenmaier K (2008) A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action. J Immunother 31:225–34
24. Rea-Neto A, Youssef NCM, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K, Sakr Y (2008) Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 12:R56
25. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl 2(Suppl 2):S27–72
26. Fàbregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, de La Bellacasa JP, Bauer T, Cabello H (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867–73
27. Young HA (2009) Cytokine multiplex analysis. Methods Mol Biol 511:85–105
28. Conway Morris A, Kefala K, Wilkinson TS, Moncayo-Nieto OL, Dhaliwal K, Farrell L, Walsh TS, Mackenzie SJ, Swann DG, Andrews PJD, Anderson N, Govan JRW, Laurenson IF, Reid H, Davidson DJ, Haslett C, Sallenave J-M, Simpson AJ (2010) Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax 65:201–7
29. Zhou X, Fragala MS, McElhaney JE, Kuchel GA (2010) Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care 13:541–7